Trials / Terminated
TerminatedNCT03157856
Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we aim to evaluate the feasibility of anti-PSMA labelling to detect post-operative prostatic tissues by two ex vivo fluorescence techniques. We will evaluate the feasibility and detection of anti-PSMA labelling by: 1. / the FEMTO-ST institute medical device, 2. / the confocal microscope that will be used to measure fluorescence spectra of biological samples.
Detailed description
For this protocol, 12 patients will be included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fluorescence assessment | All subjects of the study are going to have a radical prostatectomy. The FEMTO-ST medical device is used on 3 fresh biopsies (2 healthy and 1 malignant) which will be prelevated from the resected prostate in order to determine the prostatic or non-prostatic nature of tissue. |
Timeline
- Start date
- 2017-05-11
- Primary completion
- 2018-10-07
- Completion
- 2019-01-08
- First posted
- 2017-05-17
- Last updated
- 2019-01-15
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03157856. Inclusion in this directory is not an endorsement.